Mick Correll, Co-Founder and CEO of Genospace, was a recent guest on the TechnologyAdvice Expert Interview Series. The series explores a variety of business and technology landscapes through conversations with industry leaders.
Below are Correll’s five biggest insights from the conversation.
1. There is tremendous potential for information technology to provide valuable insight into healthcare.
However, one of the basic challenges is having the data to compute on. We didn’t think about this before. Our IT systems aren’t capturing discrete data elements. A lot of the information in the system today is locked up in narratives.
The way you captured and communicated was really a dialogue between humans because that was largely the way information was conveyed. Unfortunately, that’s not a very good input for modern big data systems.
2. We need discrete structured data, so we need to see better data capture systems within healthcare.
We need to identify where our information will come from. While we can seek to evolve the existing pieces in the organization, there’s also the opportunity to get people more directly engaged.
Engagement will get better from the healthcare provider perspective, but you’re going to see a parallel growth of the quantified self, biometric devices, and people with the ability to directly capture healthcare metrics.
So rather than all medical information coming from the very traditional healthcare encounter system, we will increasingly see people capturing information outside of that system and potentially contributing that to medical research.
3. There are three trends changing the healthcare system, which Genospace seeks to address:
- Molecular profiling will fundamentally change the way we practice medicine.
- We need to start thinking not just about one patient at a time, but how the population can scale data resources — i.e., big data. To do that, we need not just detailed molecular information but a full phenotypic picture. Family history, medical history, treatments, outcomes — together with the molecular characterization.
- The molecular data will come from sequencing labs. So where does the phenotypic piece come from? Well, if you really want to understand somebody’s medical history, why don’t you ask them? Develop a platform where individual people themselves can start to become more directly engaged.
So those pieces map into the important patient engagement trend that’s changing the healthcare system in our country. The old paternalistic system in health care was, “I trust my doctor. They’re going to make the right decision for me.” That’s not how people approach it anymore. They see themselves as active and engaged participants managing their own healthcare. They’re asking questions. They’re really one of the driving forces behind health trends and changes.
4. We’re increasingly trying to develop ways to see individuals as important stakeholders.
We need to be gearing genomics and information in a way that it is more consumer friendly. But the flip side of it is seeing people as valuable potential sources of information and giving them platforms where they can start to capture that information. They can have control. They can determine where their information is going and for what purposes.
5. Health 2.0 brings together a range of interests and viewpoints, which encourages much-needed diversity in the healthcare industry and changes the potential ways it can evolve.
I’ve never seen people come together in a way like I’m anticipating seeing at Health 2.0. It’s going to be really eye-opening. Even in our narrow discipline, there are so many hard challenges and so much interesting work happening. If you broaden that perspective to see the incredible innovation happening all around, it’s eye-opening. I’m excited to see the new ways people are approaching the system at Health 2.0.